Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome

Journal of Clinical Pathology

Volumn 54, Issue 2, 2001, Pages 126-131

  Entius, M M ^a   Keller, J J ^a   Westerman, A M ^b   Van Rees, B P ^a   Van Velthuysen, M L F ^c   De Goeij, A F P M ^d   Wilson, J H P ^b   Giardiello, F M ^e   Offerhaus, G J A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Hamartoma; Peutz Jeghers syndrome; STK11 LKB1

Indexed keywords

GENE PRODUCT; PROTEIN KINASE LKB1; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; ONCOGENE K RAS; PEUTZ JEGHERS SYNDROME; POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GASTROINTESTINAL NEOPLASMS; GENES, APC; GENES, P53; GENES, RAS; HAMARTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; PEUTZ-JEGHERS SYNDROME; PROTEIN-SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035142924     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.2.126     Document Type: Article

References (38)

1. A very remarkable case of familial polyposis of mucus membrane of intestinal tract and accompanied by peculiar pigmentations of skin and mucous membrane
2. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits
3. Increased risk for cancer in patients with the Peutz-Jeghers syndrome
4. Increased risk of cancer in the Peutz-Jeghers syndrome
5. Cancer and the Peutz-Jeghers syndrome
6. Phenotype and cancer risk of various polyposis syndromes
7. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
8. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
9. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest
10. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome
11. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis
12. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers
13. Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors
14. LKB1 somatic mutations in sporadic tumors
15. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer
16. Mutations of the STK11 gene in sporadic gastric carcinoma
17. STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer
18. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes
19. The molecular basis and clinical aspects of Peutz-Jeghers syndrome
20. Peutz-Jeghers syndrome: Confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4
21. Peutz-Jeghers disease: Most, but not all, families are compatible with linkage to 19p13.3
22. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families
23. A pericentric inversion of chromosome six in a patient with Peutz-Jeghers' syndrome and the use of FISH to localise the breakpoints on a genetic map
24. Lessons from hereditary colorectal cancer
25. Adenomatous and carcinomatous changes in hamartomatous polyps of the small intestine (Peutz-Jeghers syndrome): Report of a case and review of the literature
26. Peutz-Jeghers polyps, dysplasia, and K-ras codon 12 mutations
27. Peutz-Jeghers syndrome: 78-year follow-up of the original family
28. An Alu polymorphism intragenic to the TP53 gene
29. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
30. Immunohistochemical labelling for DPC4 mirrors genetic status in pancreatic and peripancreatic adenocarcinomas: A new marker of DPC4 inactivation
31. Potential falsepositive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms
32. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma
33. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
34. Optimizing the APC gene mutation analysis in archival colorectal tumor tissue
35. Molecular diagnosis of familial adenomatous polyposis
36. Loss of LKB1 kinase activity in Peurz-Jeghers syndrome, and evidence for allelic and locus heterogeneity
37. Colorectal tumors
38. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization